000 | 02004 a2200517 4500 | ||
---|---|---|---|
005 | 20250517183403.0 | ||
264 | 0 | _c20190114 | |
008 | 201901s 0 0 eng d | ||
022 | _a1522-1539 | ||
024 | 7 |
_a10.1152/ajpheart.00471.2017 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOduk, Yasin | |
245 | 0 | 0 |
_aVEGF nanoparticles repair the heart after myocardial infarction. _h[electronic resource] |
260 |
_bAmerican journal of physiology. Heart and circulatory physiology _c02 2018 |
||
300 |
_aH278-H284 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAngiogenesis Inducing Agents _xadministration & dosage |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aDelayed-Action Preparations |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDrug Carriers |
650 | 0 | 4 | _aDrug Compounding |
650 | 0 | 4 |
_aHuman Umbilical Vein Endothelial Cells _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice, Inbred NOD |
650 | 0 | 4 | _aMice, SCID |
650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
650 | 0 | 4 | _aNanoparticles |
650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
650 | 0 | 4 |
_aPolylactic Acid-Polyglycolic Acid Copolymer _xchemistry |
650 | 0 | 4 | _aRecovery of Function |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xadministration & dosage |
650 | 0 | 4 |
_aVentricular Function, Left _xdrug effects |
650 | 0 | 4 |
_aVentricular Remodeling _xdrug effects |
700 | 1 | _aZhu, Wuqiang | |
700 | 1 | _aKannappan, Ramaswamy | |
700 | 1 | _aZhao, Meng | |
700 | 1 | _aBorovjagin, Anton V | |
700 | 1 | _aOparil, Suzanne | |
700 | 1 | _aZhang, Jianyi Jay | |
773 | 0 |
_tAmerican journal of physiology. Heart and circulatory physiology _gvol. 314 _gno. 2 _gp. H278-H284 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajpheart.00471.2017 _zAvailable from publisher's website |
999 |
_c27752271 _d27752271 |